Behavioral Science

Recommendations

Info

Index 219 Celexa. See Citalopram Central nervous system (CNS), 75–76 Child abuse, 57–60 burns from, typical, 58 fractures from, typical, 57 leading causes of death, 196 sexual, 58–59 age range, 59 by gender, 59 incidence rates, 58 physical signs, 59 psychological signs, 59 shaken baby syndrome, 58 traits of abusers, 57 Child neglect, 57 Childbirth. See Pregnancy and childbirth Childhood disintegrative disorder, 159, 161 Children adoption, knowledge of, 12 developmental milestones, 6–8, 9–11t legal consent for, 185 neuropsychiatric disorders, 159–164 ADHD, 162 disruptive behavior disorders, 161 pervasive development disorders, 159–161 selective mutism, 163 separation anxiety disorder, 163 Tourette disorder, 72, 162–163 understanding of death, 12 Cholecystokinin (CCK), 82 CI (confidence interval), 213 Circadian rhythm sleep disorder, 45, 47 Citalopram, 95t, 167 Classical conditioning, 35–37, 36f, 39 Climacterium, 17 Clinical trial, 203 Clomipramine, 106 Close-ended questions, 179 Clozapine, 171–172 CNS (central nervous system), 75–76 Cocaine, 55, 144. See also Substance abuse Codeine, 146 Cognitive behavioral therapy (CBT), 106 Cognitive disorders, 86, 111–116. See also Delirium; Dementia amnestic syndromes, 115 delirium, 111–112 dementia, 20, 112–114 Cohort study, 202 Coining, 58 Commitment, of patients, 188 Competence, 183 Compliance. See Patient adherence Compulsions, 106 Concordance, 69 Conduct disorder, 127, 161 Confidence interval (CI), 213 Confidentiality, patient, 178, 187–188 Congenital adrenal hyperplasia, 50 Coning, 180 Conscious, as part of mind, 25 Consent, 184, 186 Continuous reinforcement, 39 Conversion disorder, 117t, 119–120 Correlation coefficient (r), 211 Countertransference, 30 Cravings, 142 Cross-sectional study, 203 Crystallized intelligence, 20 Cupping, 58 Cyclothymic disorder, 101 Cymbalta. See Duloxetine CYP2D6, 146–147 D Data sets, 210 Death and dying bereavement, 21–22, 22t children’s understanding of, 12 five stages, 21–22 Defense mechanisms, 26–30, 31–32t Delirium, 111–112 causes, 111 definition, 111 dementia v., 114t treatment, 112 Delirium tremens (DTs), 150 Delusional disorder, 86, 91 Dementia, 20, 112–114. See also Alzheimer disease amnestic syndromes v., 115 core symptoms, 112 delirium v., 114t diagnostic criteria, 112 memory and aging v., 113 prevalence, 113 types, 113–114 vascular, 113 Denial as defense mechanism, 29–30 as stage of dying, 21 Depakote. See Valproic acid Dependent personality disorder, 131–132 Dependent variables, 211 Depersonalization disorder, 136 Depression. See also Major depressive disorder anaclitic, 11 bereavement, 22, 22t body dysmorphic disorder and, 121 double, 94 ECT for, 173 in elderly, 20
220 Index Depression (Cont.): HVA and, 79 learned helplessness and, 37 mnemonic for, 93 monoamine theory, 78 postpartum, 16, 94 serotonin levels, 47 sleep disorders, 47–48 as stage of dying, 21 suicide and, 67 treatment, 94–95, 95t, 96t for postpartum, 16 with SSRIs, 94, 95t, 167 Desyrel. See Trazodone Detoxification, 142 Development through adolescence, 12 milestones, 6–8, 9–11t Tanner stages, 12, 13t theories, 3–5 Developmental retardation, 11 Dextromethorphan, 146 Diabetes, sexual dysfunction and, in males, 55 Diagnosis-related group (DRG), 192 Diazepam, 167 Disorganized speech, 87 Displacement, as defense mechanism, 27–29 Disruptive behavior disorders, 161 Dissociation, as defense mechanism, 27 Dissociative amnesia, 135 Dissociative anesthetics, 144. See also Substance abuse Dissociative fugue, 135–136 Dissociative identity disorder, 136 Disulfiram, 141 Dizygotic twins, 69, 72 Do not resuscitate (DNR) order, 185 Domestic partner abuse, 60 Donepezil, 81, 114 Dopamine hypothesis, 89 “dopamine reward pathway,” 140 Dopamines, 78–79 aggression and, 63 HVA and, 79 for psychiatric conditions, 78 sexual response and, 55 Double-blind study, 204 Down syndrome, 71, 81 Downward drift, 89 DRG (diagnosis-related group), 192 Drug(s). See also specific drugs first-order elimination, 149f manic episodes from use of, 101 sexual function and, 55–56 withdrawal from, 141–142 zero-order elimination, 148, 148f DTs (delirium tremens), 150 Duloxetine, 97t Dyspareunia, 52 Dyssomnias, 45–46 Dysthymic disorder, 94 E Early adulthood, 15–16 Eating disorder(s), 153–157 Eating Disorder Not Otherwise Specified (NOS), 156 Echolalia, 88 ECT (electroconvulsive therapy), 98–99, 173 Effexor. See Venlafaxine Ego, 25 Elder abuse, 57–60 Elder neglect, 58 Elderly, 19–23 demographics, 19 life expectancy, 19 longevity factors, 21 physiological changes, 19–20 psychological characteristics, 20 psychopathology, 20–21 Electroconvulsive therapy (ECT), 98–99, 173 Emancipated minors, 183 Emotional abuse, 59–60 Endogenous opioids, 82 Endorphins, 81 Enkephalins, 81 Epidemiology, 199–201 Epilepsy, 81 EPS (Extrapyramidal symptoms), of schizophrenia, 90–91 Equetro. See Carbamazepine Erikson, Erik, 3–4 Error types, 212–214 Errors. See Medical errors Escitalopram, 95t Eskalith. See Lithium Estrogens, 51 Ethanol glutamate receptors, 147 mechanisms of action, 147 toxicity, 143 Ethics, medical, 181–189 Ethylamine, 78, 80 Etorphine, 146 Euthanasia, 186 Excitatory neurotransmitters, 77 Exhibitionism, 54 Experimental study, 202 Extinction, 37–38 Extrapyramidal symptoms (EPS), of schizophrenia, 90–91
Page 2 and 3:
DEJA REVIEW TM Behavioral Science
Page 4 and 5:
DEJA REVIEW TM Behavioral Science S
Page 6 and 7:
To my family
Page 8 and 9:
Contents Faculty Reviewers/Student
Page 10 and 11:
Contents ix Chapter 13 MOOD DISORDE
Page 12 and 13:
Faculty Reviewers Debra L Klamen, M
Page 14 and 15:
Preface Behavioral science is an ex
Page 16 and 17:
SECTION I Human Development and Psy
Page 18 and 19:
CHAPTER 1 Early Stages of Life: Inf
Page 20 and 21:
Early Stages of Life: Infancy to Ch
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
CHAPTER 2 Middle Stages of Life: Ad
Page 32 and 33:
Middle Stages of Life: Adolescence
Page 34 and 35:
CHAPTER 3 Late Stages of Life: Agin
Page 36 and 37:
Late Stages of Life: Aging, Death,
Page 38 and 39:
Late Stages of Life: Aging, Death,
Page 40 and 41:
CHAPTER 4 Psychoanalytic Theory Wha
Page 42 and 43:
Psychoanalytic Theory 27 What are t
Page 44 and 45:
Psychoanalytic Theory 29 Which defe
Page 46:
Table 4.1 Defense Mechanism Descrip
Page 50 and 51:
Psychoanalytic Theory 33 CLINICAL V
Page 52 and 53:
CHAPTER 5 Learning Theory What is b
Page 54 and 55:
Learning Theory 37 What is the term
Page 56 and 57:
Learning Theory 39 What are the dif
Page 58 and 59:
Learning Theory 41 What is sensitiz
Page 60 and 61:
CHAPTER 6 Sleep Science and Disorde
Page 62 and 63:
Sleep Science and Disorders 45 Whic
Page 64 and 65:
Sleep Science and Disorders 47 In a
Page 66 and 67:
CHAPTER 7 Sexuality SEXUAL DEVELOPM
Page 68 and 69:
Sexuality 51 What is the sexual ori
Page 70 and 71:
Sexuality 53 Which disorder is char
Page 72 and 73:
Sexuality 55 Which postmyocardial i
Page 74 and 75:
CHAPTER 8 Abuse and Aggression CHIL
Page 76 and 77:
Abuse and Aggression 59 Which gende
Page 78 and 79:
Abuse and Aggression 61 SEXUAL VIOL
Page 80 and 81:
Abuse and Aggression 63 Why are man
Page 82 and 83:
CHAPTER 9 Suicide SUICIDE What is i
Page 84 and 85:
Suicide 67 At what stage, in treate
Page 86 and 87:
CHAPTER 10 Genetic Basis of Behavio
Page 88 and 89:
Genetic Basis of Behavior 71 Do per
Page 90 and 91:
Genetic Basis of Behavior 73 A 19-y
Page 92 and 93:
CHAPTER 11 Neurochemistry in Behavi
Page 94 and 95:
Neurochemistry in Behavioral Scienc
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
SECTION II Psychiatric Disorders an
Page 102 and 103:
CHAPTER 12 Psychotic Disorders INTR
Page 104 and 105:
Psychotic Disorders 87 Schizophreni
Page 106 and 107:
Psychotic Disorders 89 Does gender
Page 108 and 109:
Psychotic Disorders 91 What are som
Page 110 and 111:
CHAPTER 13 Mood Disorders What are
Page 112 and 113:
Mood Disorders 95 Table 13.1 SSRIs
Page 114 and 115:
Mood Disorders 97 Table 13.2 Other
Page 116 and 117:
Mood Disorders 99 What is electroco
Page 118 and 119:
Mood Disorders 101 How do you diagn
Page 120 and 121:
CHAPTER 14 Anxiety Disorders What a
Page 122 and 123:
Anxiety Disorders 105 What differen
Page 124 and 125:
Anxiety Disorders 107 What differen
Page 126 and 127:
Anxiety Disorders 109 What characte
Page 128 and 129:
CHAPTER 15 Cognitive Disorders Name
Page 130 and 131:
Cognitive Disorders 113 How does de
Page 132 and 133:
Cognitive Disorders 115 AMNESTIC SY
Page 134 and 135:
CHAPTER 16 Somatoform Disorders Wha
Page 136 and 137:
Somatoform Disorders 119 What is th
Page 138 and 139:
Somatoform Disorders 121 BODY DYSMO
Page 140 and 141:
Somatoform Disorders 123 What is th
Page 142 and 143:
CHAPTER 17 Personality Disorders Wh
Page 144 and 145:
Personality Disorders 127 What is t
Page 146 and 147:
Personality Disorders 129 What are
Page 148 and 149:
Personality Disorders 131 How can a
Page 150 and 151:
Personality Disorders 133 CLINICAL
Page 152 and 153:
CHAPTER 18 Dissociative Disorders W
Page 154 and 155:
Dissociative Disorders 137 A 42-yea
Page 156 and 157:
CHAPTER 19 Substance Abuse Disorder
Page 158 and 159:
Substance Abuse Disorders 141 How c
Page 160 and 161:
Substance Abuse Disorders 143 What
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Substance Abuse Disorders 149 Serum
Page 168 and 169:
Substance Abuse Disorders 151 CLINI
Page 170 and 171:
CHAPTER 20 Eating Disorders What ar
Page 172 and 173:
Eating Disorders 155 What are commo
Page 174 and 175:
Eating Disorders 157 A 12-year-old
Page 176 and 177:
CHAPTER 21 Child Psychiatry PERVASI
Page 178 and 179:
Child Psychiatry 161 What happens t
Page 180 and 181:
Child Psychiatry 163 In which age g
Page 182 and 183:
CHAPTER 22 Psychopharmacology What
Page 184 and 185:
Psychopharmacology 167 Which benzod
Page 186 and 187: Psychopharmacology 169 What are the
Page 188 and 189: Psychopharmacology 171 What is the
Page 190 and 191: Psychopharmacology 173 Which pharma
Page 192 and 193: SECTION III Ethics, Health Care, an
Page 194 and 195: CHAPTER 23 Clinical Practice and Di
Page 196 and 197: Clinical Practice and Difficult Sit
Page 198 and 199: CHAPTER 24 Medical Ethics and Legal
Page 200 and 201: Medical Ethics and Legal Issues 183
Page 208 and 209: CHAPTER 25 Health Care in the Unite
Page 210 and 211: Health Care in the United States 19
Page 216 and 217: CHAPTER 26 Epidemiology and Researc
Page 218 and 219: Epidemiology and Research Design 20
Page 226 and 227: CHAPTER 27 Biostatistics STATISTICA
Page 228 and 229: Biostatistics 211 What is a depende
Page 230 and 231: Biostatistics 213 If the sample siz
Page 232 and 233: Biostatistics 215 Which type of t-t
Page 234 and 235: Index A Abnormal thought formation,
Page 238 and 239: Index 221 F Factitious disorder, 11
Page 240 and 241: Index 223 Negative predictive value
Page 242 and 243: Index 225 Schizophrenia (Cont.): do
show all

Behavioral Science

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?